09:56:44 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Curaleaf Holdings Inc
Symbol CURA
Shares Issued 439,753,531
Close 2020-08-06 C$ 11.73
Market Cap C$ 5,158,308,919
Recent Sedar Documents

Curaleaf to sell Select cartridges in Florida

2020-08-06 12:58 ET - News Release

Mr. Dan Foley reports

CURALEAF'S SELECT BRAND EXPANDS INTO FLORIDA MEDICAL MARKET

Curaleaf Holdings Inc. will launch its line of Select brand products into Florida, starting with its Select Elite Live cartridges.

Select, known as America's No. 1 cannabis oil brand, has been on a path of rapid expansion since Curaleaf acquired it in February, 2020. Select products are now available at over 950 independent dispensaries across 12 states, including Arizona, California, Colorado, Connecticut, Florida, Maryland, Michigan, Nevada, Oklahoma, Oregon, Massachusetts and Maine. The Select brand will continue to expand across the United States with its launch into Ohio's medical market later this month.

As a recognized industry leader, Select is committed to maintaining the highest quality-control standards and testing transparency, and delivering the best experience possible. Select Elite Live is the brand's new enhanced live resin product, which combines high-quality tetrahydrocannabinol oil and live resin high-terpene extract. Curaleaf looks forward to unveiling more of Select's leading product offerings to Florida's medical patients soon, including the brand's best-selling, high-potency, broad-spectrum Select Elite cartridges later this year.

"With Select's expansion into Florida, we are making excellent progress in creating the first nationally recognized cannabis brand in the U.S.," said Joe Bayern, president at Curaleaf. "Beyond that, it allows us to better serve our medical patients with a variety of products that undergo the most stringent and progressive oil testing standards in the industry."

Florida's continued growth in patient registration makes it one of the nation's fastest-growing medical cannabis markets in the country. Currently, there are over 377,000 medical patients enrolled in the Florida program -- about 1.7 per cent of the state's population -- with approximately 5,000 new patients joining each week.

By way of the Medical Use of Medical Marijuana Act, vertically integrated (seed-to-sale) operations are required in the state. Therefore, Select products will be sold exclusively at Curaleaf's 28 dispensary locations in Florida. Last month, Curaleaf launched its new sublingual tablets -- a first-to-market product solely available to Florida patients. These cube-shaped, berry-flavoured bites provide a discreet, sugar-free yet fruity alternative form of medication. Sold in 30-piece jars, Curaleaf sublingual tablets contain five milligrams of high-quality cannabis oil per piece, which allows patients to manage their treatment plan with confidence and ease.

About Curaleaf Holdings Inc.

Curaleaf Holdings Inc. is a leading vertically integrated U.S. multi-state cannabis operator with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf currently operates in 23 states with 88 dispensaries, 22 cultivation sites and over 30 processing sites, and employs over 3,000 people across the United States. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.